Restor Metabolix provides diabetic treatment and metabolic disorder that treats patients through physiologic insulin resensitization.
Restor Metabolix has raised $1.0M in total funding. The most recent round was Debt Financing. The last funding was announced in October 2022.
Restor Metabolix is headquartered in Marietta, United States.
Restor Metabolix provides diabetic treatment and metabolic disorder that treats patients through physiologic insulin resensitization.
Restor Metabolix is at the Debt Financing stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Restor Metabolix — Funding & Investors." VCBacked, October 26, 2022, https://www.vcbacked.co/company/restor-metabolix. Accessed August 14, 2026.
VCBacked. (2022). Restor Metabolix — Funding & Investors. Retrieved August 14, 2026, from https://www.vcbacked.co/company/restor-metabolix
{{cite web |title=Restor Metabolix — Funding & Investors |url=https://www.vcbacked.co/company/restor-metabolix |website=VCBacked |access-date=August 14, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated